These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3732918)

  • 21. Endometrioid adenocarcinomas of the uterine corpus in women younger than 50 years of age can be divided into two distinct clinical and pathologic entities based on anatomic location.
    Hachisuga T; Fukuda K; Iwasaka T; Hirakawa T; Kawarabayashi T; Tsuneyoshi M
    Cancer; 2001 Nov; 92(10):2578-84. PubMed ID: 11745192
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic factors relating to survival in uterine endometrioid carcinoma.
    Hirai M; Hirono M; Oosaki T; Hayashi Y; Yoshihara T; Matsuzaki O
    Int J Gynaecol Obstet; 1999 Aug; 66(2):155-62. PubMed ID: 10468339
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Squamous differentiation in carcinoma of the endometrium: a critical appraisal of adenoacanthoma and adenosquamous carcinoma.
    Zaino RJ; Kurman RJ
    Semin Diagn Pathol; 1988 May; 5(2):154-71. PubMed ID: 3041509
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dedifferentiated endometrial carcinomas with neuroendocrine features: a clinicopathologic, immunohistochemical, and molecular genetic study.
    Espinosa I; De Leo A; D'Angelo E; Rosa-Rosa JM; Corominas M; Gonzalez A; Palacios J; Prat J
    Hum Pathol; 2018 Feb; 72():100-106. PubMed ID: 29133142
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic significance of squamous differentiation in stage I endometrial adenocarcinoma.
    Demopoulos RI; Dubin N; Noumoff J; Blaustein A; Sommers GM
    Obstet Gynecol; 1986 Aug; 68(2):245-50. PubMed ID: 3737041
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Metastatic mechanisms of uterine malignancies and therapeutic consequences].
    Lax SF; Tamussino KF; Lang PF
    Pathologe; 2016 Nov; 37(6):549-556. PubMed ID: 27757531
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of amine precursor administration on the morphological findings of transplanted argyrophil cell adenocarcinoma of the endometrium.
    Ueda G; Yamasaki M; Inoue M; Tanaka Y; Hiramatsu K; Inoue Y; Kurachi K
    Nihon Sanka Fujinka Gakkai Zasshi; 1982 Mar; 34(3):388-90. PubMed ID: 6175707
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endometrioid carcinoma simultaneously involving the uterus and the fallopian tube: a clinicopathologic study of 13 cases.
    Culton LK; Deavers MT; Silva EG; Liu J; Malpica A
    Am J Surg Pathol; 2006 Jul; 30(7):844-9. PubMed ID: 16819326
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Survival, prognostic factors and modern tendencies in adjuvant treatment of diagnosed endometrial cancer patients with or without lymph node dissection].
    Ivanov I
    Akush Ginekol (Sofiia); 2009; 48 Suppl 1():3-11. PubMed ID: 20387272
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endometrial argyrophil cell adenocarcinoma with indole- or catecholamine precursor uptake and decarboxylation.
    Inoue M; Ueda G; Yamasaki M; Hiramatsu K; Tanaka Y; Kurachi K; Maeyama K; Yamatodani A
    Int J Gynecol Pathol; 1982; 1(1):47-58. PubMed ID: 6135667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The prevalence and prognostic significance of argyrophil cells in colorectal carcinomas.
    Smith DM; Haggitt RC
    Am J Surg Pathol; 1984 Feb; 8(2):123-8. PubMed ID: 6322602
    [TBL] [Abstract][Full Text] [Related]  

  • 32. p53 aberrations in low grade endometrioid carcinoma of the endometrium with nodal metastases: possible insights on pathogenesis discerned from immunohistochemistry.
    Fadare O; Parkash V
    Diagn Pathol; 2017 Nov; 12(1):81. PubMed ID: 29137657
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunohistochemical study of proliferating cell nuclear antigen (PCNA) in endometrial carcinoma with argyrophil cells.
    Ueda G; Sawada M; Ogawa H; Tanizawa O; Tsujimoto M
    Gynecol Oncol; 1993 Mar; 48(3):314-6. PubMed ID: 8096489
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lymphvascular space involvement--a prognostic indicator in endometrial adenocarcinoma.
    Gal D; Recio FO; Zamurovic D; Tancer ML
    Gynecol Oncol; 1991 Aug; 42(2):142-5. PubMed ID: 1894173
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Uterine papillary serous carcinoma: a study on 108 cases with emphasis on the prognostic significance of associated endometrioid carcinoma, absence of invasion, and concomitant ovarian carcinoma.
    Carcangiu ML; Chambers JT
    Gynecol Oncol; 1992 Dec; 47(3):298-305. PubMed ID: 1473741
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Paraaortic lymph node evaluation in stage I endometrial carcinoma.
    Piver MS; Lele SB; Barlow JJ; Blumenson L
    Obstet Gynecol; 1982 Jan; 59(1):97-100. PubMed ID: 7078856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Uterine carcinosarcoma and high-risk endometrial carcinomas: a clinicopathological comparison.
    Zhang C; Hu W; Jia N; Li Q; Hua K; Tao X; Wang L; Feng W
    Int J Gynecol Cancer; 2015 May; 25(4):629-36. PubMed ID: 25633654
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Value of several morphologic tumor characteristics for prognosis of cancer of the uterine body].
    Chepik OF; Volkova AT; Bokhman IaV
    Vopr Onkol; 1976; 22(9):34-8. PubMed ID: 1007139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A clinicopathologic evaluation of "depth" in cases of endometrial adenocarcinoma].
    Sakamoto A; Hirai Y; Yamauchi K; Masubuchi K; Hasumi K
    Gan No Rinsho; 1990 May; 36(6):711-4. PubMed ID: 2348558
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PAX8 expression in uterine adenocarcinomas and mesonephric proliferations.
    Yemelyanova A; Gown AM; Wu LS; Holmes BJ; Ronnett BM; Vang R
    Int J Gynecol Pathol; 2014 Sep; 33(5):492-9. PubMed ID: 25083965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.